News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Howard Elizabeth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Howard Elizabeth (Chief Compliance Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 237,500 options to buy
@ $2.81, valued at
$667.4k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Howard Elizabeth (Executive VP & General Counsel) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 137,500 options to buy
@ $4.57, valued at
$628.4k
|
|
| 04/17/2018 |
4
| Howard Elizabeth (Exec. VP & General Counsel) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 150,000 options to buy
@ $5.2, valued at
$780k
|
|
| 04/05/2017 |
4
| Howard Elizabeth (Exec. VP & General Counsel) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 125,000 options to buy
@ $3.15, valued at
$393.8k
|
|
| 03/17/2016 |
4
| Howard Elizabeth (Exec. VP & General Counsel) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 120,000 options to buy
@ $3.94, valued at
$472.8k
|
|
| 03/17/2016 |
3
| Howard Elizabeth (Exec. VP & General Counsel) has filed a Form 3 on Arbutus Biopharma Corp |
|
|